- You must be logged in to add items to the cart.
Nucleofill™ Hair
$127.99
Description
Nucleofill™ Hair is a non-invasive treatment for clients suffering from androgenetic alopecia or cases of hair damage or thinning.
Key Features
- Hair loss reduction.
- Improvement of hair quality.
- Improvement of hair thickness.
- Thickening of hair brow.
Specifications
- Main Ingredient:
- Manufacturer:
- Drug Class:
- Generic Name:
- Package Contents:
- Storage Requirements:
- Main Usage:
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
RRS® HA Long Lasting
Newderm Lift – Nouveau Visage®
Newderm Hair – Nouveau Visage®
Related Articles
Saypha Filler: Premium Fillers for Aesthetic Clinics
Aesthetic medicine continues to rise in demand with patients looking for treatments that are not…
Skin Boosters Injections: Aesthetic Solutions that Work
Interest in non-invasive aesthetic treatments is on the rise, and skin booster injections have become…
Top‑Quality Wholesale Dermal Fillers for Aesthetic Practices
As aesthetic clinics face increasing competition, sourcing wholesale dermal fillers has become a strategic advantage.…
Liporase Hyaluronidase: Trusted Enzyme for Aesthetic Filler Correction
When filler results miss the mark, clinics need a reliable solution that works fast and…
Mesotherapy Injections: Non-Surgical Rejuvenation That Works
Mesotherapy injections present an appealing, non-surgical solution that aligns with the growing demand for low-downtime,…
Aesthetic Treatments for Men: Trends and Tailored Options
The demand for aesthetic treatments for men has been steadily rising over the past few…
The Benefits of Azelac RU for Skin Health and Aesthetics
In today’s clinical aesthetics landscape, practitioners are increasingly turning to innovative solutions like Azelac RU…
How Science-Meets-Nature Skincare Products Shape Aesthetics
In today’s evolving world of aesthetics, medical practitioners are seeing a shift in patient preferences.…